Andrew Pitt, MD
Dermatology · Lake Oswego, ORNPI 1275699118
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.3% of the total across 459 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AbbVie at 27.2% of the total.
Across 459 payments — averaging $18.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$2K
- Lilly USA, LLC$1K
- Novartis$482
- Pfizer$455
- Regeneron Healthcare Solutions, Inc.$359
- plus $2K from 20 others
What the payments were for
- Food & beverage$8,16894%
- Education$4946%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 133 | $2,357 |
| Johnson & Johnson | 108 | $1,849 |
| Lilly USA, LLC | 58 | $1,263 |
| Novartis | 27 | $482 |
| Pfizer | 21 | $455 |
| Regeneron Healthcare Solutions, Inc. | 20 | $359 |
| Amgen | 19 | $351 |
| E.r. Squibb & Sons, L.L.C. | 7 | $234 |
| UCB, Inc. | 9 | $218 |
| Sun Pharmaceutical Industries Inc. | 9 | $203 |
| Helsinn Therapeutics (U.S.), Inc. | 7 | $131 |
| Dermira, Inc. | 6 | $96 |
| Sanofi | 4 | $96 |
| Incyte Corporation | 4 | $91 |
| Arcutis Biotherapeutics, Inc. | 4 | $75 |
| Dermavant Sciences, Inc. | 3 | $71 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $67 |
| Galderma Laboratories, L.p. | 3 | $63 |
| Merck | 3 | $45 |
| Biofrontera Inc. | 4 | $40 |
| Medtronic | 1 | $23 |
| LEO Pharma Inc. | 1 | $20 |
| Boehringer Ingelheim | 1 | $20 |
| Smith+Nephew | 1 | $19 |
| Almirall LLC | 1 | $18 |
| VYNE Pharmaceuticals Inc. | 1 | $15 |
How this compares
$8,662 in reported general payments places this provider in the 85th percentile of 175 dermatology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 145 | $7,255 |
| Doxycycline Hyclate | 151 | $2,292 |
| Metronidazole | 25 | $1,890 |
| Triamcinolone Acetonide | 131 | $1,853 |
| Desonide | 48 | $1,671 |
| Ketoconazole | 55 | $853 |
| Betamethasone Dipropionate | 23 | $842 |
| ValacyclovirValacyclovir Hcl | 23 | $578 |
| Cephalexin | 83 | $525 |
| Tetracycline Hcl | 12 | $390 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 48 | $312 |
| Mupirocin | 17 | $289 |
| MethotrexateMethotrexate Sodium | 15 | $220 |
| Hydrocortisone | 16 | $199 |
| Minocycline Hcl | 16 | $193 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Lake Oswego
- Betty JiangLake Oswego$6K
- Stephen AustadLake Oswego$5K
- Andrew BlauveltPortland$1.8M
- Benjamin EhstPortland$1.5M
- Jason HawkesPortland$1.5M
- Eric SimpsonPortland$1.4M
- Collin BlattnerThe Dalles$409K
- Alex Ortega LoayzaPortland$122K
- Omar QutubPortland$107K
- Paul HaunPortland$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.